Genentech Avastin launch timeline
Executive Summary
Genentech is producing Avastin in anticipation of approval of the colorectal cancer therapy by its March 31 user fee date. However, the company has not begun putting the product into commercial dosage forms, which could cause launch to be delayed by at least one month. [Editor's Note: More coverage the Avastin launch timeline will appear in 1"The Pink Sheet" DAILY. Visit our website, www.ThePinkSheetDAILY.com, to sign up for a free trial.]...